Aaron Craig Jessop, M.D., M.B.A.
Department of Nuclear Medicine, Division of Diagnostic Imaging
About Dr. Aaron Craig Jessop
Aaron C. Jessop, MD, MBA currently serves as Assistant Professor of Nuclear Medicine at the University of Texas MD Anderson Cancer Center. He joined MD Anderson in 2010 after completion of residency training in Nuclear Medicine at Vanderbilt University Medical Center. He is active as a clinician and educator in the Department of Nuclear Medicine and serves as the Section Chief of Clinical Nuclear Medicine. His research interests include clinical applications of PET/CT and SPECT/CT as well as therapeutic nuclear medicine procedures, with an emphasis on oncologic applications.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Chief, Section of Clinical Nuclear Medicine (CNM), Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Clinical applications of PET/CT and SPECT/CT Therapeutic nuclear medicine procedures, with an emphasis on oncologic applications.
Education & Training
Degree-Granting Education
| 2014 | Cornell University, Ithaca, NY, USA, MBA, Master of Business Administration |
| 2006 | University of Nebraska Medical School, Omaha, NE, USA, MD, Doctor of Medicine |
| 2002 | Utah State University, Logan, UT, USA, BA, Liberal Arts and Sciences |
Postgraduate Training
| 2007-2010 | Chief Resident, Vanderbilt Nuclear Medicine Residency Program, Nashville, TN |
| 2007-2010 | Nuclear Medicine Residency, Vanderbilt University Medical Center, Nashville, TN |
| 2006-2007 | Internal Medicine Internship, Griffin Hospital - Yale Teaching Affiliate, Derby, CT |
Board Certifications
| 2010 | The American Board of Nuclear Medicine |
Experience & Service
Academic Appointments
Assistant Professor, Division of Department of Diagnostic & Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2013 - 2017
Instructor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2011
Honors & Awards
| 2016 | President's Recognition of Faculty Excellence Honoree, The University of Texas MD Anderson Cancer Center |
| 2014 | Celebrating Improvement at MD Anderson-Optimizing Intradermal Injections, Office of Performance Improvement |
| 2009 | Fellow Teacher of the Year, Vanderbilt University Radiology Residents |
| 2009 | Faculty Teacher of the Year, Vanderbilt Nuclear Medicine Technology Program |
| 2008 | Faculty Teacher of the Year, Vanderbilt Nuclear Medicine Technology Program |
| 2002 | Top Liberal Arts Student Award, Utah State University |
| 2002 | Academic Scholarship, University Of Nebraska College of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Recca K, Muneeb A, Helstern C, Lemieux B, Das S, Jessop A. Evaluation of Patient Transmission Factor Following the Administration of 177Lu-DOTATATE. Health Phys. e-Pub 2022. PMID: 36099424.
- Kairemo K, Jessop AC, Vija AH, Ding X, Spence D, Kappadath SC, Macapinlac HA. A Prospective Comparative Study of Using Ultrasonography, 4D-CT and Parathyroid Dual-Phase Scintigraphy with SPECT in Patients with Primary Hyperparathyroidism. Diagnostics (Basel) 11(11), 2021. e-Pub 2021. PMID: 34829354.
- Das S, Du L, Schad A, Jain S, Jessop AC, Shah C, Eisner D, Cardin D, Ciombor K, Goff L, Bradshaw M, Delbeke D, Sandler M, Berlin J. A clinical score for neuroendocrine tumor patients under consideration for Lu-177-DOTATATE therapy. Endocr Relat Cancer 28(3):203-212, 2021. PMID: 33608484.
- Khattab MH, Sherry AD, Jessop AC, Ciombor KK, Chakravarthy B. Early detection of SARS-CoV-2 from staging PET-CT. J Radiat Oncol 9(3-4):93-95, 2020. e-Pub 2020. PMID: 33014283.
- Delbeke D, Newman G, Deppen S, Shah C, Ndolo J, Shi C, Bailey CE, Jessop AC, Sandler MP. 68Ga-DOTATATE: Significance of Uptake in the Tail of the Pancreas in Patients Without Lesions. Clin Nucl Med 44(11):851-854, 2019. PMID: 31524686.
- Vija AH, Bartenstein PA, Froelich JW, Kuwert T, Macapinlac H, Daignault CP, Gowda N, Hadjiev O, Hephzibah J, Huang P, Ilhan H, Jessop A, Cachovan M, Ma J, Ding X, Spence D, Platsch G, Szabo Z. ROC study and SUV threshold using quantitative multi-modal SPECT for bone imaging. Eur J Hybrid Imaging 3(1):10, 2019. e-Pub 2019. PMID: 34191147.
- Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Curr Oncol Rep 19(12):83, 2017. e-Pub 2017. PMID: 29081018.
- Rayamajhi SJ, Lee J, Mittal BR, Jessop AC, Chasen B, Bhosale P. Cross sectional and nuclear medicine imaging of pancreatic insulinomas. Abdom Radiol (NY) 42(2):531-543, 2017. e-Pub 2016. PMID: 27639564.
- Erwin WD, Jessop AC, Mar MV, Macapinlac HA, Mawlawi OR. Qualitative and quantitative comparison of gated blood pool single photon emission computed tomography using low-energy high-resolution and SMARTZOOM collimation. Nucl Med Commun 38(1):35-43, 2017. e-Pub 2016. PMID: 27775993.
- Amini B, Jessop AC, Ganeshan DM, Tseng WW, Madewell JE. Contemporary imaging of soft tissue sarcomas. J Surg Oncol. e-Pub 2014. PMID: 25348367.
- Oki Y, Chuang H, Chasen B, Jessop A, Pan T, Fanale M, Dabaja B, Fowler N, Romaguera J, Fayad L, Hagemeister F, Rodriguez MA, Neelapu S, Samaniego F, Kwak L, Younes A. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Br J Haematol 165(1):112-6, 2014. e-Pub 2014. PMID: 24386943.
Abstracts
- Khouri Issa, Erwin Bill, Jessop Aaron. Stratified Intense-Dose-Yittrium-90 Ibritumumab Tiuxetan (90IT) with Bendamustine+Fludarabine Nonmyeloablative Conditioning for Allogeneic Stem Cell Transplantation in b-Cell Malignancies. ASH Abstract: Oral Presentation 58th Annual Meeting and Exposition Published online Dec 1, 2016 supplemental volume of Blood(662), 2016.
- Kairemo KJ, Jessop A, Kappadath SC, Macapinlac HA. A prospective comparative study of using ultrasonography (US), 4D-CT and parathyroid dual-phase scintigraphy with SPECT in patients with primary hyperparathyroidism. The Journal of Nuclear Medicine 57, Supplement 2:131P, 2016.
- Bache ST, Adrada BE, Jessop A, Rauch GM, Kappadath SC. Quantification of tumor uptake with molecular breast imaging. The Journal of Nuclear Medicine 57, Supplement 2, 2016.
- Erwin W, Khouri I, Gress D, Kappadath S, Jessop A. Target organ dose range-based, high activity Zevalin -inclusive, non-myeloablative conditioning for allogeneic stem cell transplantation: a stratified approach. The Journal of Nuclear Medicine 57, Supplement 2, 2016.
- Khouri IF, Sui D, Turturro F, Erwin WD, Bassett RL, Korbling M, Valverde R, Ahmed S, Alousi AM, Anderlini P, Bashir Q, Ciurea SO, Oran B, Olson A, Popat UR, Patel KK, Qazilbash MH, Fanele MA, Fayad LE, Nastoupil L, Westin JR, Gulbis AM, Medeiros LJ, Young KH, Jessop A. In-Vivo Purging with Rituximab (R) Followed by Z/BEAM/R Autologous Stem Cell Conditioning for Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Mature Results from a Combined Analysis of 3 Trials. American Society of Hematology, 2015.
- Cabanillas ME, Waquespack SG, Pitteloud M, Roman-Gonzalez A, Jessop AC, Santos EB, Davies MA, Dadu R. Anti-CTLA4-induced Graves Disease (GD): A rare cause of hyperthyroidism (hyperT) in patients (pts) with metastatic melanoma (MM). Thyroid 25 (S1)(P-1-A-337), 2015.
- Bache S, Adrada B, Jessop A, Rauch G, Kappadath S. Scatter and attenuation correction approaches for quantitative molecular breast imaging. Journal of Nuclear Medicine 56 (Supplement 3):45, 2015.
- Erwin W, Jessop A, Peirsol W, Mar M, Jones S, Macapinlac H, Mawlawi O. Qualitative and quantitative comparison of gated blood pool SPECT using low-energy high-resolution and SMARTZOOM collimation. Journal of Nuclear Medicine 55 (Supplement 1):1736, 2014.
- Costelloe C, Jessop AC, Madewell JE, Chuang H, Haygood TM. FDG PET/CT of Primary Bone Tumors. American Journal of Roentgenology 198 (5 Supplement):E533, 2012.
- Bawa T, Jessop AC, Rohren EM, Delbeke D. FDG PET/CT of patients with melanoma: Clinical impact of imaging the lower extremities. Journal of Nuclear Medicine 52 (Supplement 1):1918, 2011.
- Jessop AC, Yan X, Delbeke D. Complimentary role of 11C-acetate and 18F-FDG in the evaluation of hepatocellular carcinoma (HCC): The Vanderbilt Experience. Journal of Nuclear Medicine 51 (Supplement 2):68, 2010.
- Yan X, Jessop AC, Patton J, Delbeke D. Comparison of left ventricular function determined by gated 64-slice CT and SPECT. Journal of Nuclear Medicine 51 (Supplement 2):434, 2010.
- Jessop AC, Walker RC, Delbeke D. Accuracy of 64-slice coronary CT angiography (CCTA) for the diagnosis of functionally significant coronary artery disease (CAD) on SPECT stress/rest myocardial perfusion scintigraphy (MPS). Journal of Nuclear Medicine 50 (Supplement 2):1143, 2009.
Book Chapters
- Jessop AC, Delbeke D. Pancreas and Liver. In: A Case-Based Approach to PET/CT in Oncology. Cambridge University Press, 242-266, 2012.
- Jessop AC, Walker R, Delbeke D. Tumors of the Central Nervous System. In: Hybrid PET/CT and SPECT/CT Imaging - A Teaching File. Springer, 99-136, 2010.
- Walker R, Jones-Jackson L, Jessop AC, Delbeke D. PET/CT Imaging of Lung Cancer. In: Hybrid PET/CT and SPECT/CT Imaging - A Teaching File. Springer, 171-216, 2010.
- Walker R, Jones-Jackson L, Jessop AC, Delbeke D. PET/CT Imaging of Melanoma. In: Hybrid PET/CT and SPECT/CT Imaging - A Teaching File. Springer, 555-582, 2010.
Patient Reviews
CV information above last modified August 13, 2024